Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Development and Evaluation of an Online Shared Decision-Making Educational Program for Nurses and Patients With Chronic Diseases

NCT07589673 · tracked via the Priya Life Science South Korea tracker
Sponsor
Chungnam National University
Phase
Not applicable
Started
2026-05-10
Last updated
2026-05-26

Condition(s) studied

Chronic DiseaseShared Decision-making

Investigational drug(s) / intervention(s)

Online Shared Decision-Making Educational Program for NursesOnline Shared Decision-Making Educational Program for Patients With Chronic DiseasesGeneral Communication Education for NursesGeneral Health Information for Patients With Chronic Diseases

Online Shared Decision-Making Educational Program for Nurses: The nurse program is a 4-week web-based shared decision-making educational program for nurses working in general hospitals. It is designed to enhance nurses' knowledge and skills in shared decision-making, decision support, and patient communication through self-directed online learning.

Online Shared Decision-Making Educational Program for Patients With Chronic Diseases: The patient program is a 4-week web-based shared decision-making educational program for adults with chronic diseases. It is designed to support patients in participating in shared decision-making by helping them prepare for decisions, explore options, and clarify their values and preferences.

General Communication Education for Nurses: The control condition consists of access to publicly available communication-related educational materials, such as those provided by the Nursing Human Resources Employment Education Center.

General Health Information for Patients With Chronic Diseases: The control condition consists of access to publicly available health management information, such as that provided by the National Health Information Portal.

Study summary

This study aims to develop and evaluate an online shared decision-making (SDM) educational program for nurses and patients with chronic diseases. Shared decision-making is a process in which healthcare professionals and patients make health-related decisions together based on the best available evidence and the patient's values and preferences. The study includes an evaluation phase. In the evaluation phase, the program will be tested among nurses working in general hospitals and adults with chronic diseases living in the community. Outcomes related to shared decision-making will be assessed at baseline, immediately after the 4-week program, and 1 month later. The study is expected to improve shared decision-making competence, experience, and preparedness among both nurses and patients.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria for Nurse: * Registered nurses currently providing direct patient care in participating general hospitals * Able to understand the purpose and procedures of the study and provide informed consent * Able to use a computer, tablet, or smartphone to access the online program Exclusion Criteria for Nurse: * Not currently engaged in direct patient care * Unable to clearly express willingness to participate * Unable to complete the educational program or questionnaires because of technical or language limitations Inclusion Criteria for Patients: * Adults aged 19 years or older living in the community * Diagnosed with one or more chronic diseases requiring ongoing management, including but not limited to hypertension, diabetes mellitus, dyslipidemia, arthritis, chronic respiratory disease, or cardiovascular disease, with at least 3 months elapsed since diagnosis * Able to understand the purpose and procedures of the study and provide informed consent * Able to read and respond to survey questions * Able to use a computer, tablet, or smartphone to access the online program Exclusion Criteria for Patients: * Cognitive impairment or communication problems that make participation difficult * Unable to complete the educational program or questionnaires because of technical or language limitations

Primary outcome measure(s)

  • Change in nurses' shared decision-making competence — Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
    Nurses' shared decision-making competence will be assessed using a shared decision-making competence scale for nurses. The scale consists of 26 items with total scores ranging from 26 to 130. Higher scores indicate greater shared decision-making competence. Changes in scores from baseline to each follow-up assessment will be compared between the intervention and control groups.
  • Change in patients' shared decision-making experience — Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
    Patients' shared decision-making experience will be assessed using the Shared Decision-Making Questionnaire-9 items(SDM-Q-9). The SDM-Q-9 consists of 9 items, with total raw scores ranging from 0 to 45. Higher scores indicate a greater level of patient-perceived shared decision-making. Changes in scores from baseline to each follow-up assessment will be compared between the intervention and control groups.

Trial sites (1)

FacilityCityRegionStatus
Chungnam National University Daejeon South Korea Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07589673 on ClinicalTrials.gov ↗ ← All trials in South Korea